article thumbnail

Routine vaccinations drop among U.S. kindergartners for the third year in a row

STAT

kindergartners who’ve received standard childhood vaccines took a small but notable dip into the 2021-2022 school year, health officials said Thursday, amid disruptions related to Covid-19 and fears that anti-vaccine sentiment stirred up by the pandemic could be spreading to other shots. The percentage of U.S.

Vaccines 363
article thumbnail

Gates Foundation to fund trial of long-awaited new tuberculosis vaccine candidate

STAT

The Gates Foundation unveiled plans Wednesday to fund a long-awaited trial for what, if proven effective, would be the first new tuberculosis vaccine in over a century. The 26,000-person, Phase 3 study, set to begin next year, will test a vaccine known as M72/AS01 that showed promising results from a smaller trial in 2019.

Vaccines 308
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: The coronavirus lab leak hypothesis is damaging science

STAT

Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 — is well known. There are two competing hypotheses, one of which is hindering the process of scientific discovery and could hold back the development of vaccines and other antiviral agents in the U.S. How it began is a matter of heated controversy.

Vaccines 363
article thumbnail

STAT+: Pharmalittle: We’re reading about a GSK vaccine deal, an Alzheimer’s drug approval, and more

STAT

Moderna scored a partial victory in its attempt to claim a share of billions of dollars in profits made by Pfizer and BioNTech from selling Covid-19 vaccine, after a judge in London ruled that one of its two patents was valid , according to Bloomberg News. Pfizer and BioNTech had filed a lawsuit in the U.K.

Vaccines 237
article thumbnail

BioNTech takes its first cancer vaccine into phase 2

pharmaphorum

It would be easy to forget that back in 2019, BioNTech was an early-stage biotech firmly focused on cancer vaccines, before being catapulted onto the world-stage with its COVID-19 shot. The post BioNTech takes its first cancer vaccine into phase 2 appeared first on.

Vaccines 145
article thumbnail

Accelerating AMR vaccine development

European Pharmaceutical Review

In July 2022, the World Health Organization (WHO) released its inaugural report on the pipeline of vaccines currently in development to prevent infections caused by antimicrobial resistance (AMR) bacterial pathogens. WHO referred to 61 bacterial vaccine candidates in diverse stages of clinical development. 1 WHO’s analysis was stark.

Vaccines 115
article thumbnail

SAEM Clinical Images Series: Post-Vaccination Rash

ALiEM - Pharm Pearls

A 42-year old Bengali man with a history of hyperlipidemia presented to the Emergency Department with facial swelling, diffuse rash, renal insufficiency and proteinuria after receiving his COVID-19 vaccine (Moderna) booster dose. Erythema multiforme has been reported as a cutaneous reaction after the COVID-19 mRNA vaccine.

Vaccines 130